Drug Approval | July 26, 2023
Eugia Pharma receives USFDA approval for Plerixafor Injection
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
Metoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure.
Subscribe To Our Newsletter & Stay Updated
